Resolutions at the extraordinary general meeting in ADDvise Group AB (publ)

At the extraordinary general meeting in ADDvise Group AB (publ) (“ADDvise”) held today on 16 February 2026, Mia Tomczak and Richard Jernberg were elected as new board members of the company. The resolution means that the board of directors shall consist of Fredrik Celsing (chairman), Mia Tomczak, and Richard Jernberg for the period until the … Read more

Year-end report 2025, January 1–December 31

Increased profits, profitability and stable cash flow. In the fourth quarter, organic sales increased by 4.0% in constant currency and an increase of 1.5% for the full year 2025. Our focus on operational efficiency during the year means that EBITA increased by SEK 5.1 million in the fourth quarter, while the EBITA margin amounted to … Read more

Delisting of the shares and warrants in ADDvise from Nasdaq First North

On 29 January 2026, ADDvise Group AB (publ) (“ADDvise”) announced that its board of directors had applied for delisting of the shares and warrants in ADDvise from Nasdaq First North Premier Growth Market (“First North”) in accordance with the request from Amplex AB, which in connection with its public offer has become the owner of … Read more

Notice of extraordinary general meeting in ADDvise Group AB (publ)

The shareholders of ADDvise Group AB (publ) (“ADDvise”), 556363-2115, are hereby summoned to an extraordinary general meeting to be held at 10:00 a.m. (CET) on 16 February 2026 at Gernandt & Danielsson Advokatbyrå at Hamngatan 2 in Stockholm, Sweden. Entry and registration begin at 09:30 a.m. (CET). The general meeting is convened at the request … Read more

ADDvise announces financial update for 2025

On 10 December 2025, Amplex AB (“Amplex” or the “Bidder”) announced a public offer to the holders of shares and warrants in ADDvise Group AB (publ) (“ADDvise” or the “Company”) to transfer all their shares and warrants in the Company to Amplex (the “Offer”). To provide shareholders and warrant holders in ADDvise with the necessary … Read more

ADDvise receives the bondholders’ approval in the written procedure under its outstanding bonds 2025/2028

ADDvise Group AB (publ) (the “Company” or “ADDvise”) announces that the Company has received the bondholders’ approval of the proposed amendments in the written procedure under the terms and conditions of the Company’s outstanding bonds 2025/2028 with ISIN SE0025011885 (the “Bonds”) that was initiated on 2 January 2026 (the “Written Procedure”). The Written Procedure was … Read more

ADDvise initiates a written procedure under its outstanding bonds 2025/2028 in light of the public offer from Amplex

ADDvise Group AB (publ) (the “Company” or “ADDvise”) has instructed the agent under the Company’s outstanding bonds 2025/2028 with ISIN SE0025011885 (the “Bonds”) to initiate a written procedure in which the Company requests that the bondholders approve certain amendments to the terms and conditions of the Bonds (the “Written Procedure”). The proposed amendments in the … Read more